Moghimi Sasan

Soltani Ghazaleh, Nishida Takashi, Moghimi Sasan, Micheletti Eleonora, Hashemi Seyedehmelika, de Oliveira Pereira Amelia et al.

In glaucoma suspects, microvascular dropout and β-zone PPA progression were independently linked to optic disc structural progression, highlighting these as early markers for timely intervention.

Mahmoudinezhad Golnoush, Moghimi Sasan, Pawar Varun, Cheng Jiacheng, Walker Evan, Beheshtaein Siavash et al.

AI identified 11 distinct macular thinning patterns, outperforming global thickness in predicting central visual field progression. This improves individualized glaucoma risk assessment and management.

Gunasegaran Gopikasree, Moghimi Sasan, Nishida Takashi, Liebmann Jeffrey M, Fazio Massimo A, Girkin Christopher A et al.

This study found central visual field progression identified more fast progressors across all glaucoma stages than global measures, highlighting the need to monitor central vision closely.

Kamalipour Alireza, Moghimi Sasan, Khosravi Pooya, Tansuebchueasai Natchada, Camp Andrew Steven, Vasile Cristiana et al.

ROTA revealed widespread RNFL bundle defects in glaucoma, especially papillomacular and papillofoveal bundles. Their presence significantly predicts central visual field loss, even in early disease.

Nishida Takashi, Weinreb Robert N, Walker Evan, Girkin Christopher A, Fazio Massimo A, Liebmann Jeffrey M et al.

This study compared visual field progression methods in glaucoma patients with central defects, finding 10-2 VF tests detected more central progression, highlighting 24-2 VF alone may underestimate it.

Wu Jo-Hsuan, Nishida Takashi, Moghimi Sasan, Walker Evan, Zangwill Linda M, Weinreb Robert N

This study found no racial difference in glaucoma progression detection time using OCT/OCTA. However, OCTA detected progression faster than OCT in both African and European descendants, suggesting its potential to enhance monitoring.

Pham Vincent Q, Nishida Takashi, Moghimi Sasan, Alam Naimul, Girkin Christopher A, Fazio Massimo A et al.

Initial OCT-measured cpRNFL loss rates predict future glaucoma progression, with faster early loss indicating higher risk. This helps clinicians predict disease course and guide patient management.

Mahmoudinezhad Golnoush, Moghimi Sasan, Ru Liyang, Yong Yu Xuan, Yang Dongchen, Cheng Jiacheng et al.

Deep learning accurately estimated visual fields from optic nerve OCTA images, outperforming traditional methods. This could potentially reduce the frequency of visual field testing for glaucoma patients.

Jiravarnsirikul Anuwat, Belghith Akram, Rezapour Jasmin, Micheletti Eleonora, Nishida Takashi, Moghimi Sasan et al.

This study found larger choriocapillaris dropout near the optic nerve is significantly linked to central visual field damage in glaucoma patients, regardless of myopia, which could help identify those at higher risk.

Soltani Ghazaleh, Nishida Takashi, Moghimi Sasan, Tran Elaine, Yamane Maya, Girkin Christopher et al.

This study found optic nerve head prelaminar schisis, especially severe forms, is linked to faster visual field loss in glaucoma, suggesting it's a biomarker for progression risk.

Mahmoudinezhad Golnoush, Moghimi Sasan, Latif Kareem, Brye Nicole, Walker Evan, Nishida Takashi et al.

Studying macular OCT frequency for glaucoma progression, researchers found testing twice yearly is often sufficient to detect progression, balancing sensitivity and healthcare burden, though thrice yearly is more sensitive.

Gunasegaran Gopikasree, Moghimi Sasan, Walker Evan, Nishida Takashi, Liebmann Jeffrey M, Fazio Massimo A et al.

This study found central visual field progression impacts glaucoma patients' quality of life more than global progression, suggesting current assessments may underestimate patient-centered outcomes.

Seo Je Hyun, Nishida Takashi, Moghimi Sasan, Wu Jo-Hsuan, Fazio Massimo A, Girkin Christopher A et al.

This study found higher physical activity levels independently slowed visual field loss in glaucoma patients, suggesting exercise may protect against disease progression.

Meller Leo L T, Kashaf Michael Saheb, Sambo Angel, Cizmic Julian, Chen Jeffrey, Moghimi Sasan et al.

Only half of registered glaucoma trials are published, often with significant delays, suggesting potential bias in the disseminated glaucoma research.

Wu Jo-Hsuan, Moghimi Sasan, Nishida Takashi, Adelpour Mohsen, Kamalipour Alireza, Gunasegaran Gopikasree et al.

This study found optic nerve head microvasculature loss occurs earlier and correlates better with visual field damage than macular loss in glaucoma, suggesting OCTA can monitor early disease.

Pham Vincent Q, Nishida Takashi, Moghimi Sasan, Girkin Christopher A, Fazio Massimo A, Liebmann Jeffrey M et al.

This study found that both higher average blood pressure and greater blood pressure variability are associated with faster visual field progression in glaucoma, suggesting BP management is crucial.

Nishida Takashi, Moghimi Sasan, Gunasegaran Gopikasree, Walker Evan, Wu Jo-Hsuan, Rahmatnejad Kamran et al.

Metformin use in glaucoma patients was linked to thicker retinal nerve fiber layer and higher capillary density, suggesting a potential protective effect warranting further study.

Jiravarnsirikul Anuwat, Belghith Akram, Rezapour Jasmin, Bowd Christopher, Moghimi Sasan, Jonas Jost B et al.

Diagnosing glaucoma in myopic eyes is challenging due to structural and visual field confounds, requiring careful interpretation of standard diagnostic tests for effective patient management.

Meller Leo L T, Saseendrakumar Bharanidharan Radha, Mahmoudinezhad Golnoush, Tavakoli Kiana, Wu Jo-Hsuan, Parikh Aman et al.

This study found that consuming 4 or more alcoholic drinks per week is associated with a significantly increased risk of primary open-angle glaucoma, particularly in women, suggesting a need for patient counseling.

Rao Harsha L, Dasari Srilakshmi, Puttaiah Narendra K, Pradhan Zia S, Moghimi Sasan, Mansouri Kaweh et al.

In mild-moderate PACG, younger age and higher peak IOP, but not baseline OMAG, predicted faster RNFL loss, suggesting OMAG's limited role in predicting structural progression.

Mohammadzadeh Vahid, Liang Youwei, Moghimi Sasan, Xie Pengtao, Nishida Takashi, Mahmoudinezhad Golnoush et al.

A deep learning model effectively detected glaucoma progression using longitudinal macular OCTA images, outperforming traditional methods. This could enhance early clinical detection and management.

Nishida Takashi, Moghimi Sasan, Jin Wang, Zangwill Linda M, Weinreb Robert N

Atrial fibrillation and related microvascular damage were linked to slightly faster visual field loss in glaucoma patients, highlighting the need to manage cardiovascular risk factors.

Mahmoudinezhad Golnoush, Moghimi Sasan, Micheletti Eleonora, Du Kelvin H, Adelpour Mohsen, Latif Kareem et al.

This study found increased retinal oxygen saturation is significantly associated with worse visual field damage in glaucoma patients, suggesting a potential biomarker for disease severity.

Wu Jo-Hsuan, Moghimi Sasan, Walker Evan, Nishida Takashi, Liebmann Jeffrey M, Fazio Massimo A et al.

In individuals of African descent, OCT (RNFLT) detected glaucoma progression significantly earlier than visual fields, supporting its importance for monitoring this population.

Wu Jo-Hsuan, Moghimi Sasan, Walker Evan, Nishida Takashi, Liebmann Jeffrey M, Fazio Massimo A et al.

This study found long-term retinal nerve fiber layer thickness variability is small in glaucoma patients of African and European descent. Cataract surgery was the strongest predictor of variability; excluding it eliminated racial differences, suggesting RNFLT reliability across races.